Skip to main content

CITIGROUP INC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 831001 NEW YORK, NY

Position in AMLX

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$441,769
-$17,656 QoQ
Shares Held
31,782
-16.4% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Derivatives in AMLX

reported options exposure · as of Dec 31, 2023
CallValue
$1,055,424
CallShares
71,700
PutValue
$1,055,424
PutShares
71,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CITIGROUP INC holds $466,960,504 across 57 Drug Manufacturers - Specialty & Generic names. AMLX ranks #30 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMLX

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $441,769 31,782
2025-12-31 $459,425 38,032
2025-09-30 $517,547 38,083
2025-06-30 $199,336 31,098
2025-03-31 $1,639,868 463,240
2024-12-31 $2,303,243 609,324
2024-09-30 $1,863,015 575,005
2024-06-30 $1,260,413 663,376
2024-03-31 $2,597,823 914,727
2023-12-31 $1,055,424 71,700
2023-12-31 $5,706,413 387,664
2023-12-31 $1,055,424 71,700
2023-09-30 $801,776 43,789
2023-09-30 $1,065,642 58,200
2023-09-30 $1,065,642 58,200
2023-06-30 $1,309,299 60,700
2023-06-30 $1,309,299 60,700
2023-06-30 $1,673,162 77,569
2023-03-31 $146,700 5,000
2023-03-31 $971,916 33,126
2023-03-31 $880,200 30,000
2022-12-31 $1,962,045 53,100
2022-12-31 $359,264 9,723
2022-12-31 $1,962,045 53,100
2022-09-30 $245,496 8,721
2022-09-30 $2,074,655 73,700
2022-09-30 $3,347,035 118,900
2022-06-30 $16,082 835
2022-03-31 $14,828 1,154